Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 725-733

  Beagles, K E ^a   Peterson, L ^a   Zhang, X ^a   Morris, J ^a   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GENE PRODUCT; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CD34 SELECTION; CELL POPULATION; CELL STIMULATION; CONTROLLED STUDY; DOG; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENE;

ANIMALS; CYCLOSPORINE; CYTOKINES; DOGS; GREEN FLUORESCENT PROTEINS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

CANIS FAMILIARIS; PRIMATES;

EID: 20844445621     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.725     Document Type: Article

References (25)

1. + cells. J. Virol. 74, 1286-1295.
2. AN, D.S., KUNG, S.K., BONIFACINO, A., WERSTO, R.P., METZGER, M.E., AGRICOLA, B.A., MAO, S.H., CHEN, I.S., and DONAHUE, R.E. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J. Virol. 75, 3547-3555.
3. BEINKE, S., and LEY, S.C. (2004). Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochem. J. 382, 393-409.
4. DENG, W.P., YANG, W.K., LAI, W.F., LIU, R.S., HWANG, J.J., YANG,. D.M., FU, Y.K., and WANG, H.E. (2004). Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type I thymidine kinase and ganciclovir. Eur. J. Nucl. Med. Mol. Imaging 31, 99-109.
5. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J.A., DOREN, S., CARTER, C., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, F.M., LEITMAN, S.F., WILSON, W.H., COWAN, K., YOUNG, N.S., and NIENHUIS, A.W. (1995). Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057.
6. GAUR, U., and AGGARWAL, B.B. (2003). Regulation of proliferation, survival and apoptosis by members of the TNF superfamily [review]. Biochem. Pharmacol. 66, 1403-1408.
7. HANAZONO, Y., TERAO, K., SHIBATA, H., NAGASHIMA, T., AGEYAMA, N., ASANO, T., UEDA, Y., KATO, I., KUME, A., HASEGAWA, M., and OZAWA, K. (2002). Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates. J. Gene Med. 4, 470-477.
8. HEIM, D.A., HANAZONO, Y., GIRI, N., WU, T., CHILDS, R., SELLERS, S.E., MUUL, L., AGRICOLA, B.A., METZGER, M.E., DONAHUE, R.E., TISDALE, J.F., and DUNBAR, C.E. (2000). Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol. Ther. 1, 533-544.
9. HEYNINCK, K., and BEYAERT, R. (2001). Crosstalk between NF-κB-activating and apoptosis-inducing proteins of the TNF-receptor complex [review]. Mol. Cell Biol. Res. Commun. 4, 259-265.
10. HORN, P.A., KEYSER, K.A., PETERSON, L.J., NEFF, T., THOMASSON, B.M., THOMPSON, J., and KIEM, H.-P. (2004). Efficient lentiviral gene transfer to canine repopulating cells using an overnight transduction protocol. Blood 103, 3710-3716.
11. KATZ, M.H., SPIVACK, D.E., TAKIMOTO, S., FANG, B., BURTON, D.W., MOOSSA, A.R., HOFFMAN, R.M., and BOUVET, M. (2003). Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter. Ann. Surg. Oncol. 10, 762-772.
12. MCSWEENEY, P.A., NIEDERWIESER, D., SHIZURU, J.A., SANDMAIER, B.M., MOLINA, A.J., MALONEY, D.G., CHAUNCEY, T.R., GOOLEY, T.A., HEGENBART, U., NASH, R.A., RADICH, J., WAGNER, J.L., MINOR, S., APPELBAUM, F.R., BENSINGER, W.I., BRYANT, E., FLOWERS, M.E.D., GEORGES, G.E., GRUMET, F.C., KIEM, H.-P., TOROK-STORB, B., YU, C, BLUME, K.G., and STORB, R.F. (2001). Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97, 3390-3400.
13. MINAMI, Y., KONO, T., MIYAZAKI, T., and TANIGUCHI, T. (1993). The IL-2 receptor complex: Its structure, function, and target genes [review]. Annu. Rev. Immunol. 11, 245-268.
14. MOENS, U., MATHIESEN, I., GHELUE, M.V., and REKVIG, O.P. (2002). Green fluorescent protein modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo. Mol. Immunol. 38, 505-514.
15. MORRIS, J.C., CONERLY, M., THOMASSON, B., STOREK, J., RIDDELL, S.R., and KIEM, H.-P. (2004). Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning. Blood 103, 492-499.
16. OH, S.C., NAM, S.Y., KWON, H.C., KIM, C.M., SEO, J.S., SEONG, R.H., JANG, Y.J., CHUNG, Y.H., and CHUNG, H.Y. (2001). Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron. Mol. Cells 11, 192-197.
17. + hematopoietic cells. Blood 97, 1951-1959.
18. RUGGIERI, L., AIUTI, A., SALOMONI, M., ZAPPONE, E., FERRARI, G., and BORDIGNON, C. (1997). Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum. Gene Ther. 8, 1611-1623.
19. SOLING, A., THEISS, C., JUNGMICHEL, S., and RAINOV, N.G. (2004). A dual function fusion protein of herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma. Genet. Vaccines Ther. 2, 7.
20. SOLOMON, S.R., NAKAMURA, R., READ, E.J., LEITMAN, S.F., CARTER, C., CHILDS, R., DUNBAR, C.E., YOUNG, N.S., and BARRETT, A.J. (2003). Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation. Bone Marrow Transplant. 31, 783-788.
21. STORB, R., DEEG, H.J., WHITEHEAD, J., APPELBAUM, F., BEATTY, P., BENSINGER, W., BUCKNER, C.D., CLIFT, R., DONEY, K. , FAREWELL, V., HANSEN, J., HILL, R., LUM, L., MARTIN, P., MCGUFFIN, R., SANDERS, J., STEWART, P., SULLIVAN, K., WITHERSPOON, R., YEE, G., and THOMAS, E.D. (1986). Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N. Engl. J. Med. 314, 729-735.
22. STRIPECKE, R., DEL CARMEN VILLACRES, M., SKELTON, D.C., SATAKE, N., HALENE, S., and KOHN, D.B. (1999). Immune response to green fluorescent protein: Implications for gene therapy. Gene Ther. 6, 1305-1312.
23. SWAIN, S.L. (1991). Lymphokines and the immune response: The central role of interleukin-2 [review]. Curr. Opin. Immunol. 3, 304-310.
24. TJUVAJEV, J.G., JOSHI, A., CALLEGARI, J., LINDSLEY, L., JOSHI, R., BALATONI, J., FINN, R., LARSON, S.M., SADELAIN, M., and BLASBERG, R.G. (1999). A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia (New York) 1, 315-320.
25. XUE, F., QI, Y.P., JOSHUA, M.N., LAN, P., and DONG, C.Y. (2003). Conditional replication of a recombinant adenovirus studied using neomycin as a selective marker. J. Biochem. Mol. Biol. 36, 275-281.